United States: President-Elect Biden's Potential Executive Actions: A Health Care & Life Sciences Perspective - Akin Gump Strauss Hauer & Feld LLP

Mondaq

24 Nov 2020 0 shares 1 views

United States: President-Elect Biden's Potential Executive Actions: A Health Care & Life Sciences Perspective - Akin Gump Strauss Hauer & Feld LLP

Mondaq

Published 24 Nov 2020

President-elect Biden's agenda and approach for his first 100 days in office will depend to a large degree on which party controls the United States Senate.

Full Article

United States: Summary Of Trump Administration Drug Pricing And AKS Rulemakings And Implications For Life Sciences Companies And Health Care Providers - Foley Hoag LLP

Mondaq 27 Nov 2020

On Friday, November 20, 2020, 60 calendar days prior to the inauguration of President-Elect Biden, the Trump administration..

More coverage

United States: OFAC Releases Advisory On Sanctions Risk Involving Ransomware Payments - Akin Gump Strauss Hauer & Feld LLP

In early October, the United States Department of Treasury's Office of Foreign Assets Control (OFAC) issued an advisory, warning of..

Mondaq 04 Nov 2020

United States: President-Elect Biden's Potential Executive Actions: A Health Care & Life Sciences Perspective - Akin Gump Strauss Hauer & Feld LLP

United States: President-Elect Biden's Potential Executive Actions: A Health Care & Life Sciences Perspective - Akin Gump Strauss Hauer & Feld LLP

You might like

Related news coverage

United States: Summary Of Trump Administration Drug Pricing And AKS Rulemakings And Implications For Life Sciences Companies And Health Care Providers - Foley Hoag LLP

Advertisement

More coverage

United States: OFAC Releases Advisory On Sanctions Risk Involving Ransomware Payments - Akin Gump Strauss Hauer & Feld LLP